Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Bibliographic Details

Published in:	Pharmacological research 2023-10, Vol.196, p.106938-106938, Article 106938
Main Authors:	Zapata-Cobo, Paula, Salvador-Matín, Sara, Velasco, Marta, Palomino, Laura M., Clemente, Susana, Segarra, Oscar, Moreno-Álvarez, Ana, Fernández-Lorenzo, Ana, Pérez-Moneo, Begoña, Montraveta, Montse, Sánchez, Cesar, Tolín, Mar, Loverdos, Inés, Fobelo, María José, Navas-López, Victor Manuel, Magallares, Lorena, García-Romero, Ruth, Sánchez-Hernández, José Germán, Rodríguez, Alejandro, Bossacoma, Ferrán, Balboa, María Jesús, Salcedo, Enrique, Sanjurjo-Sáez, María, López-Fernández, Luis A.
Format:	Article
Language:	eng
Subjects:	Adalimumab Inflammatory bowel disease Infliximab Pediatric Pharmacogenetics Polymorphism
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!